Have you heard about the latest analysis of QIAGEN shares? $QGEN heard? The private bank Berenberg has lowered the price target from 54.90 euros to 48.00 euros, but left the rating at "Buy". Analyst Sam England emphasizes that the fourth quarter was solid, even if the outlook for 2025 was somewhat disappointing.
However, the company's key growth pillars show promising momentum, which could point to long-term growth. In XETRA trading today, QIAGEN shares fell 0.7 percent to 37.24 euros, which means that there is still 28.89 percent upside to the new price target.
Since the beginning of the year, the share has already lost 15.9 percent, which makes the current situation even more interesting. QIAGEN will present its financial results for the first quarter of 2025 on May 5, 2025.
How do you see the further development of the QIAGEN share? Do you think the company can turn things around? 👍